ArticleCureus2026
Contrast-Induced Encephalopathy Due to Contrast Extravasation From a Chronic Post-hemorrhagic Encephalomalacic Region: Prior Hemorrhage as a Potential Risk Factor.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contrast-induced encephalopathy (CIE) is a rare complication of iodinated contrast administration, typically presenting with transient neurological symptoms ranging from confusion to coma. It is most commonly reported after intra-arterial procedures involving large contrast volumes and occurs more frequently in patients with risk factors such as renal impairment, hypertension, and prior central nervous system (CNS) injury. We report a unique case of a 64-year-old woman with end-stage renal disease (ESRD) on hemodialysis, a remote right temporoparietal lobar hemorrhage, and a recent left thalamic hemorrhage who developed decreased consciousness following CT angiography (CTA) with a relatively low dose of intravenous contrast. Imaging revealed contrast extravasation localized to the site of her prior lobar hemorrhage, without evidence of new bleeding. The patient gradually improved with supportive care, including hemodialysis. To our knowledge, this is the first reported case of CIE caused by contrast leakage into a chronic post-hemorrhagic encephalomalacic region. This case suggests that longstanding blood-brain barrier (BBB) disruption from prior hemorrhage may predispose ESRD patients to contrast-induced neurotoxicity even at low contrast doses. Clinicians should exercise caution when administering contrast to patients with ESRD and prior CNS injury, and further studies are warranted to guide contrast use and preventive strategies in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.